Article
SULT 1A3 single-nucleotide polymorphism and the single dose pharmacokinetics of inhaled salbutamol enantiomers: are some athletes at risk of higher urine levels?
Drug testing and analysis - 1 Feb 2015
Jacobson Glenn A, Yee Kwang Choon, Wood-Baker Richard, Walters E Haydn
Abstract excerpt
The study was designed to investigate the effect of a common genetic variation of the main salbutamol metabolizing enzyme SULT1A3 (single nucleotide polymorphism 105A>G, rs1975350) on the stereoselective pharmacokinetics of salbutamol. Subjects were administered a 400 µg dose of inhaled salbutamol via a large volume spacer and blood samples were collected over 4 h. Plasma levels of (R)- and (S)-salbutamol were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
